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Alzheimer’s disease (AD), the most common form of dementia, disproportionately affects
women in both prevalence and severity. This increased vulnerability to AD in women
is strongly associated with age-related ovarian hormone loss and apolipoprotein E 4
allele (ApoE4), the most important genetic risk factor for sporadic AD. Up to date,
the mechanism involved in the interaction between ApoE4 and sex/gender in AD is
still unclear. This study evaluated the sex-dependent ApoE4 effects on learning and
memory, Aβ deposition and potential mechanisms, using mice bearing both sporadic
(ApoE4) and familial (APPSwe, PS1M146V, tauP301L; 3xTg) AD risk factors and compared
with sex- and age-matched 3xTg or nonTg mice. Compared to nonTg mice, transgenic
mice of both sexes showed spatial learning and memory deficits in the radial arm water
maze and novel arm discrimination tests at 20 months of age. However, at 10 months,
only ApoE4/3xTg mice showed significant learning and memory impairment. Moreover,
molecular studies of hippocampal tissue revealed significantly higher protein levels of
Aβ species, β-site APP cleavage enzyme (BACE1) and Sp1, a transcription factor
of BACE1, in female ApoE4/3xTg when compared with female nonTg, female 3xTg,
and male ApoE4/3xTg mice. Significantly increased BACE1 enzymatic activities were
observed in both male and female mice carrying ApoE4; however, only the females
showed significant higher BACE1 expressions. Together, these data suggest that ApoE4
allele is associated with increased BACE1 enzymatic activity, while female sex plays
an important role in increasing BACE1 expression. The combination of both provides
a molecular basis for high Aβ pathology and the resultant hippocampus-dependent
learning and memory deficits in female ApoE4 carriers.
Keywords: sex-dependent effect, ApoE4, BACE1, learning and memory, Alzheimer’s Disease
Abbreviations: AD, Alzheimer’s disease; ApoE, apolipoprotein E; APP, amyloid precursor protein; Aβ, amyloid beta; BACE1,
β-site APP cleavage enzyme; ER, estrogen receptor; FAD, familial Alzheimer’s disease; ITI, inter-trial interval; NAD, novel arm
discrimination; PERK, protein kinase RNA-like endoplasmic reticulum kinase; RAWM, radial arm water maze.
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INTRODUCTION
Alzheimer’s disease, a devastating neurodegenerative disorder,
accounts for 60–80% of all dementia among individuals who are
≥65 years of age (Barker et al., 2002; Blennow et al., 2006; Wilson
et al., 2012). The magnitude of its reach is shown both through its
standing as the third leading cause of death in the United States
(US) and through the immense burden of care associated with
its progression (Hurd et al., 2013; Freedman and Spillman, 2014;
James et al., 2014). Moreover, among the top ten causes of death
reported by the US National Center for Health Statistics (2015)
AD remains the only one that cannot be prevented or cured.
Furthermore, AD incidence rate is increasing, and it is expected
that by 2050, 13.8 million of the US population will be living with
AD (Hebert et al., 2013).
Multifactorial etiologies of AD link it to multiple risk factors
rather than a single cause. Epidemiological studies have shown
gender diﬀerences in both the incidence and severity of AD,
with women at much greater risk, even after adjusting for
longer life span and education levels (Fratiglioni et al., 1997;
Jorm and Jolley, 1998; Andersen et al., 1999; Fratiglioni et al.,
2000; Barker et al., 2002). Compared to aﬀected men, women
with AD have signiﬁcant increases in global neuropathology
and worse dementia ratings (Barnes et al., 2005). Meanwhile,
the ε4 allele of the ApoE has been strongly conﬁrmed as a
genetic risk factor for sporadic AD (Raber et al., 2004; Loy
et al., 2014), with the other two isoforms, ε2 and ε3, respectively,
decreasing the likelihood of AD or having a neutral eﬀect. ApoE4
carriers are at a 3- to 12-fold higher risk of developing AD than
ApoE3 carriers, depending on gene dose (Corder et al., 1993).
ApoE4 carriers also experience earlier onset, faster progression,
and more pronounced deﬁcits during disease development than
ApoE3 carriers (Raber et al., 2004; Cosentino et al., 2008; Sando
et al., 2008; Reinvang et al., 2013). Moreover, ApoE4 and gender
have prominent interaction, with the ApoE4 link to AD far
more pronounced in women than in men (Corder et al., 2004;
Fleisher et al., 2005; Lehmann et al., 2006; Damoiseaux et al.,
2012; Altmann et al., 2014; Ungar et al., 2014). Women with
ApoE4 experience greater gross hippocampal pathology, more
severememory deﬁcit, lower cognitive scores, lower hippocampal
volumes, more senile plaque, and higher spinal ﬂuid levels of
tau, along with a higher risk for AD than men (Bretsky et al.,
1999; Corder et al., 2004; Fleisher et al., 2005; Lehmann et al.,
2006; Damoiseaux et al., 2012; Altmann et al., 2014). Similar
sex diﬀerences are also shown in transgenic mouse models of
AD, with females showing earlier and more robust deﬁcits than
males. For example, older female mice with familiar AD (FAD)
mutations exhibit higher brain amyloid β (Aβ) levels and poorer
cognitive performance than age-matched males (Wang et al.,
2003; Halford and Russell, 2009; Carroll et al., 2010). Age-
dependent ApoE4-induced impairments in spatial learning and
memory are also seen in female, but not in male mice (Raber
et al., 1998; Raber et al., 2000; Bour et al., 2008; Reverte et al.,
2012). Our search of the literature, however, yielded few cognitive
assessments of ApoE4-sex eﬀects in transgenic mice with FAD
mutations. Such studies are needed, as these mutations have been
shown to produce similar AD pathology seen in human brains
(Johnson-Wood et al., 1997; Oddo et al., 2003; LaFerla andGreen,
2012).
Although the sex-dependent ApoE4 eﬀects on cognitive
function are strongly associated with increased Aβ levels in AD
brains (Corder et al., 2004; Liu et al., 2014; Ungar et al., 2014),
the underlying molecular mechanisms are still unclear. Excessive
Aβ accumulation, one of the neuropathological hallmarks in AD,
is produced through amyloidogenic pathway via a sequential
cleavage of the APP by β-secretase and γ-secretase (Selkoe,
2001; Vassar, 2004). Evidence from animal and cell culture
studies suggests that the β-site APP cleavage enzyme (BACE1)
is the major β-secretase in the brain, serving as the rate-limiting
enzyme in amyloidogenesis (Cai et al., 2001; Luo et al., 2001;
Li et al., 2006; McConlogue et al., 2007; Cole and Vassar, 2008;
Cai et al., 2012). Increased BACE1 levels and activities have been
shown in AD brains (Fukumoto et al., 2002; Yang et al., 2003;
Li et al., 2004), with a further increase in cerebrospinal ﬂuid
(CSF) or brains of AD subjects with ApoE4 (Stockley et al., 2006;
Ewers et al., 2008). However, other studies showed no diﬀerence
in BACE1 activity or reduced BACE1 levels in ApoE4 carriers
(Mulder et al., 2010; Decourt et al., 2013). Nevertheless, few
of these studies have included sex diﬀerences as confounding
factors.
To investigate how the interaction of ApoE4 and sex
contributes to cognitive impairment and to BACE1-dependent
amyloidogenesis, as well as to identify possible mechanisms
underlying this interaction, we compared behavioral and
molecular measures in an AD mouse model carrying the
human ApoE4 allele plus triple transgenes with FAD mutations
(PS1M146V, APPSwe, and tauP301L; 3xTg). These familial
mutations are known to produce both Aβ plaques and
neuroﬁbrillary tangles in the aging mouse brain (Oddo
et al., 2003). To distinguish possible contributions from ApoE4,
all results were compared with 3xTg and nonTg background
controls. Our results suggest that the combination of ApoE4
allele and female sex contributes to the increased BACE1
enzymatic activity and expression, respectively. It provides
a molecular basis for high Aβ pathology and the resultant




All procedures were in compliance with the University of
Mississippi Medical Center Institutional guidelines, approved
by the UMMC Institutional Animal Care and Use Committee
(IACUC) and in accordance with NIH guidelines for the use of
vertebrate animals.
A total of 156 mice used in this study were age (10 and
20month-old) and sexmatched nonTg, 3xTg (PS1M146V, APPSwe,
and tauP301L) and ApoE4/3xTg (PS1M146V, APPSwe, tauP301L, and
hApoE4) mice. The mice were obtained from the laboratory of
Dr. Frank LaFerla of the University of California, Irvine. The
animals were maintained at the University of Mississippi Medical
Center, group housed in a temperature/humidity controlled
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environment with free access to food and water, and kept on a
12 h light/dark cycle with lights on at 6 a.m. and lights oﬀ at
6 p.m. The number of animals used in diﬀerent studies are listed
in Table 1.
3xTg mice were generated by microinjecting two independent
transgene constructs that encode human APPSwe and tauP301L
into single-cell embryos, and then harvested from mutant
homozygous PS1M146V knockin mice (Oddo et al., 2003). To
determine the eﬀect of replacing mouse ApoE with human
ApoE4, 3xTg mice were crossed with the human ApoE4 knockin
mice to generate ApoE4/3xTg mice (Oddo et al., 2009), in which
the human ApoE4 gene is expressed under the control of murine
ApoE promotor (Knouﬀ et al., 1999).
Vaginal Smear
The estrus cycle stage and fertility of the female mice, across all
age groups, were determined by collecting samples of vaginal
mucosa at the same time (10 am) each day for 2 weeks, as
described by McLean et al. (2012). Each vaginal mucosa sample
was slightly smeared on a single glass slide, allowed to dry
completely at room temperature, and then subjected to crystal
violet staining by immersion in crystal violet for 1 min. This
process was followed by destaining in ddH2O for 1 min, after
which the stained smear was topped with glycerol, covered
by a coverslip, and observed under a light microscope. Phases
of the estrus cycle (proestrus, estrus, metestrus, diestrus) were
determined based on the mucosal cell types identiﬁed in the
samples.
Radial Arm Water Maze
The RAWM, a behavioral test described by Alamed et al. (2006)
for evaluating learning and spatial/working memory, was slightly
modiﬁed, as previously described (Adeosun et al., 2013). Our
apparatus consisted of a 1m diameter pool, divided into ﬁve alleys
(Supplementary Figure S1), each a navigable alley of 40 cm length
and 15–20 cm width leading to a 22 cm diameter circle at the
TABLE 1 | Experimental design.
Study Genotype Sex Age
Age and genotype
effects in AD mice
nonTg Male and
female
10 M (n = 9) 20 M (n = 8)
3xTg Male and
female
10 M (n = 10) 20 M (n = 8)
ApoE4/3xTg Male and
female
10 M (n = 8) 20 M (n = 8)
Sex and age effects
in ApoE4/3xTg mice
ApoE4/3xTg Male 10 M (n = 10) 20 M (n = 9)
Female 10 M (n = 10) 20 M (n = 8)
Sex and genotype
effects in AD mice
nonTg Male 10 M (n = 12)
Female 10 M (n = 10)
3xTg Male 10 M (n = 12)
Female 10 M (n = 12)
4xTg Male 10 M (n = 12)
Female 10 M (n = 10)
The number of animals used in studies for age-, sex- and genotype-dependent
differences in AD mice.
pool’s center. In one arm (the target arm), a 10 cm× 10 cm square
transparent platform was placed 5 cm from the wall and 0.5 cm
beneath the water’s surface to serve as the target throughout all
training trials.
During training, each mouse was gently placed into one of
the four arms (but not the target arm) and allowed a maximum
time of 60 s to ﬁnd the platform hidden in the target arm; if
the platform was not located during this time, we gently guided
the mouse to it. Although the platform’s location was altered
for diﬀerent animals, it was consistently maintained for each
individual animal until the end of the training session. During
2 days of RAWM testing, working with cohorts of 4–5 mice at a
time, a total of eight training blocks were performed, with two
training trials per animal per block, for a total of 16 attempts
by each animal. The start arm was randomized throughout the
eight training blocks. In all cases, the numbers of wrong arm
entries (errors), along with time to ﬁnd the platform (latency),
were recorded. One hour after the end of the training, the hidden
platform was removed and a 1 min probe trial was performed.
The probe trial was recorded, and the video was analyzed using
Noldus EthoVision XT 8.5 software (Noldus, Leesburg, VA,
USA). Data from animals that remain in the start arm for the
entire probe trial were excluded from the results. In the RAWM,
the average latency and error from each block was compared
to the corresponding data from the ﬁrst training block and also
compared between each genotype using two-way ANOVA and
post hoc test. The percentage of time that each animal spent in the
target arm (T) was calculated as follows: T% = (100% xT)/(time
spent in all the alleys). T% was compared to a 20% chance level
using a one-sample T-test to show whether or not the animal was
able to learn and remember the location of the hidden platform,
and was also compared using two-way ANOVA to examine the
sex and genotype eﬀects among groups.
Novel Arm Discrimination
To study spatial memory, which is hippocampus-dependent, we
used the NAD task (Place memory task) (Supplementary Figure
S2). This test is based on the natural tendency of rodents to
show preference for a novel environment over a familiar one. As
previously described (Adeosun et al., 2013), the test was carried
out in the Y-maze apparatus, using a ﬂoor covered with the wood
chippings used in mice cages. Diﬀerent objects were placed to
serve as extra-maze cues at various distances around the maze.
The test involved two trials: an acquisition and a retention trial,
separated by a 1 h ITI. During acquisition trials, one arm was
blocked. The blocked arm was the Novel arm (N) and the other
arm was the Familiar arm (F); the remaining arm was the Start
arm (S), which remained open and was kept constant in both
trials. In the acquisition trial, each animal was placed in the Start
arm of the maze and then allowed to explore both the Start and
the Familiar arms (F) for 5 min. After 1 h, the Novel arm (N) was
opened and the animal was allowed to explore again for 5 min.
The walls of the maze were cleaned with 70% alcohol and the
wood chippings covering the ﬂoor of the maze were mixed before
the next animal was placed in the maze. While the Start arm (S)
was kept constant for all animals, the Novel and Familiar arms
were counterbalanced among the animals within each group. The
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experiment was recorded with the Noldus system and the video
was analyzed oﬄine using Noldus EthoVision XT 8.5 software.
Data from animals that remain in the start arm for either
acquisition or retention trial were excluded from the results.
In the NAD, the percentage of time spent in N was calculated
as follows: N% = (100% × N)/(N+F). N% was compared to
a 50% chance level using a one-sample t-test. Whether or not
the animal discriminated between the novel and other arm was
indicted by an inequality in the time spent in either arm. N% was
also compared using two-way ANOVA to determine the sex and
genotype eﬀects between groups.
Tissue Collection
Before euthanasia, mice were anesthetized with isoﬂurane. After
vascular ﬂushing by cardiac perfusion using saline, brains were
harvested on an ice-cooled plate. The hippocampus was dissected
from the right hemispheres and immediately wrapped in pre-
labeled aluminum foils, snap-frozen in liquid nitrogen, and
stored at −80◦C until ready for protein extraction.
In each experimental group, three hippocampal samples were
subjected to the extraction buﬀer for β-secretase activity assay,
and rest of the samples were subjected to RIPA buﬀer for protein
extraction. The statistical signiﬁcance of the following molecular
studies was assessed by two-way ANOVA and a subsequent
Bonferroni post hoc test. Diﬀerences were considered signiﬁcant
at probability (P) values less than 0.05.
Protein Extraction
Protein was extracted from the hippocampus sample as
previously described (Adeosun et al., 2012), with modiﬁcations.
Brieﬂy, each samples was homogenized in 200 μl of cold DEPC
water with a pestle motor mixer (MIDSCI, St. Louis, MO,
USA) for 20 s. A 135 μl of the homogenate was immediately
transferred into a tube already containing 135 μl of RIPA-HALT
protease inhibitor cocktail mix (1:100) (Halt from Thermo-
scientiﬁc; Rockford, IL, USA). The homogenate-RIPA mix was
left at 4◦C for 30 min and centrifuged at 11,000 rpm at 4◦C in
a refrigerated centrifuge (Eppendorf, Hauppauge, NY, USA) for
12 min. The supernatant was then transferred into a fresh tube
and centrifuged again at 11,000 rpm for 15 min at 4◦C. This
supernatant was then again transferred into the ﬁnal protein tube
as cytoplasmic protein. The pellet from the ﬁrst centrifugation
was ﬁrst washed twice with PBS and then sonicated (Qsonica,
LLC, Newtown, CT, USA) three times with an additional 50 μl
of RIPA-HALT at 15A for 10 s to release nuclear protein. The
protein concentration of each sample was determined by the BCA
Protein Assay Kit (Pierce Biotechnology, Rockford, IL, USA)
before being prepared for gel electrophoresis.
SDS PAGE and Immunoblotting
Protein extracts were prepared using RIPA-Halt mix to attain
the same ﬁnal concentration for gel electrophoresis. Three
parts of protein were then mixed with one part 4× laemmli
buﬀer (BP-110R, Boston BioProducts, Ashland, MA, USA).
The protein-laemmli mix was heated at 95◦C, while mixing,
for 5 min; it was then allowed to cool on ice for 2 min.
A Mini-PROTEAN Tetra cell (Bio-Rad, Hercules, CA, USA)
was used as a running chamber for vertical gel electrophoresis.
Cytoplasmic proteins of six samples per group were used for
Aβ and BACE1 detection, and nuclear proteins were used for
Sp1 detection. Samples (30 μg/well) were loaded on a 10%
polyacrylamide gel, along with the precision protein plus western
blot ladder (Bio-rad, Hercules, CA, USA), and run at 90 V for
2 h. The protein was transferred to a PVDF membrane using
the Trans-Blot Turbo Transfer System (Bio-rad, Hercules, CA,
USA). Next, the protein was blotted on a PVDF membrane
with Pierce Fast Western Blot Kit, ECL Substrate (Pierce
Biotechnology, Rockfod, IL, USA), which contains washing
buﬀer, antibody diluent, optimized HRP reagent, and ECL
Detection Reagents. Speciﬁcally, the membrane was washed with
washing buﬀer and incubated with primary antibody BACE1
(D10E5, 5606S, 1:250, Cell Signaling) and Sp1 (1C6, sc-420,
1:100, Santa Cruz) for 30 min at room temperature. The
membrane was then immediately incubated with the optimized
HRP reagent at 1:10 dilution for 10 min. After washing three
times, the membrane was incubated with ECL substrate for
5 min and the chemiluminiscent signal detected by the Bio-Rad
ChemiDocTM XRS+ system (Bio-Rad, Hercules, CA, USA) with
Image lab 3.0 software every 30 s for 10 min. Protein sample
loading was normalized with β-Actin (AC-15, ab6276, 1:10000,
Abcam), detected on the same membrane after stripping. Data
were presented as relative optical densities of the individual
bands± SEM. In addition to Two-way ANOVA and post hoc test,
a correlation between Sp1 and BACE1 protein expression was also
examined.
Dot Blot
Dot blot was used to detect the protein expression of Aβ species
in the hippocampal tissues. Proteins extracts of four samples per
group were normalized with RIPA-Halt mix to reach the same
ﬁnal concentration and used in the dot blot. Speciﬁcally, the grid
was drawn on a pre-cut nitrocellulose membrane by pencil to
indicate the region for each sample to blot. Using narrow-mouth
pipette tip, 30 μg of samples were spotted onto the membrane at
the center of the grid. The membrane was then allowed to dry
and blotted with primary antibody anti-Aβ peptide (MOAB-2,
MABN254, 1:1000, Millipore) in the same manner as described
for immunoblotting. This antibody is highly speciﬁc for Aβ
peptide, with higher selectivity for the more neurotoxic Aβ42
compared to Aβ40.
β-secretase Activity Fluorometric Assay
β-site APP cleavage enzyme1 enzymatic activity in hippocampal
tissues was measured by the β-secretase activity ﬂuorometric
assay kit (#K360-100, BioVision, Milpitas, CA, USA) according
to the instructions. The lyophilized active β-secretase was
reconstituted by adding 10 μl of ddH2O and refrozen
immediately at −80◦C. 35 μl of fresh hippocampal homogenate
from each sample wasmixed with 70μl ice-cold extraction buﬀer.
It was then incubated on ice for 30 min and centrifuged at
10,000×g for 5 min. After the centrifugation, the supernatant
was transferred to a new tube and the protein concentration
of supernatant measured with BCA Protein Assay-Reducing
Agent Compatible (Pierce Biotechnology, Rockford, IL, USA).
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50 μl of protein extract was added to each well in a 96-
well plate. 2 μl of reconstituted active β-secretase with 50 μl
of extraction buﬀer was used as a positive control, and
2 μl of the β-secretase inhibitor with 50 μl sample served
as a negative control. The 50 μl of 2× Reaction Buﬀer
and 2 μl of β-secretase substrate was added to each well.
The plate was then gently mixed and incubated in the dark
at 37◦C for 1 h. When the incubation was complete, the
plate was read by a Synergy 2 Multi-Mode Reader (BioTek,
Winooski, VT, USA) with Ex. 345 nm and Em. 505 nm.
Background readings obtained from the blank control were
subtracted from all samples. β-secretase activity was expressed
as relative ﬂuorescence units per μg of protein sample
(RFU).
RESULTS
Age- and Sex-dependent Effects of
ApoE4 on Learning and Memory in AD
Mice
The ﬁndings from our RAWM studies, detailed below, support
that ApoE4 contributes to profound deﬁcits in learning and
memory seen in young (10 months-old) female ApoE4/3xTg
mice, which may be associated with hormonal ﬂuctuation
initiated around this age range.
Probe trial RAWM ﬁndings for young (10 months) and old
(20 months) nonTg, 3xTg and ApoE4/3xTg mice (Figure 1A)
showed a signiﬁcant genotype eﬀect (F2,45 = 19.27, p < 0.0001)
and a trend for age eﬀect (F1,45 = 4.013, p = 0.0512). In
this “ﬁve-arm” maze, young (p < 0.001) and old (p < 0.001)
nonTg mice spent signiﬁcantly greater than 20% of their
time in the target arm. By contrast, only young 3xTg mice
spent signiﬁcantly more time in that arm (p < 0.001 vs.
20%; p < 0.05 vs. old 3xTg mice). Neither young nor
old ApoE4/3xTg mice stayed in the target arm for longer
than 20% of the time measured. These data suggest that
ApoE4 induces an early learning and memory deﬁcits in AD
mice.
To determine sex-dependent ApoE4 eﬀects during aging, male
and female ApoE4/3xTg mice in the same age ranges (10 and
20 months) were compared in RAWM (Figure 1B). Signiﬁcant
eﬀects of age (F1,33 = 8.363, p < 0.01), sex (F1,33 = 4.171,
p < 0.05) and age-sex interaction (F1,33 = 6.118, p < 0.05) on
learning andmemory were observed. Male, but not female, young
ApoE4/3xTg mice spent signiﬁcantly longer time in the target
arm (p < 0.001 vs. 20%; p < 0.01 vs. female). However, neither
old males nor old females exhibited a preference for the target
arm.
Among female laboratory rodents of most genotypes,
the initiation of irregularity in the estrous cycle occurs at
approximately 9–10 months of age (Nelson et al., 1982;
Rubin, 2000; Maﬀucci and Gore, 2006; Brinton, 2012). Using
vaginal smear, we assessed estrous stages of our mice as an
indicator of their sex hormone changes. In crystal violet
staining, three major cell types were observed in vaginal
mucosa samples, including nucleated epithelial cells, corniﬁed
squamous epithelial cells and leukocytes. The estrous cycle
stage was determined by the relative proportion of each cell
types seen in the sample (Supplementary Figure S3) (Caligioni,
2009; McLean et al., 2012): Proestrus was characterized by
clusters of round nucleated epithelial cells; During estrus,
cells were predominantly corniﬁed squamous epithelial
cells, occurring in packed clusters; In both metestrus and
diestrus, mixed cell types were observed, with great portion
of leukocytes and occasionally corniﬁed squamous epithelial
cells or nucleated epithelial cells, respectively. Given the
smear results, we conﬁrmed in our transgenic animals that
cycle length becomes irregular and prolonged (>5 days) as
compared to the normal 4–5 days cycle length at around
9–10 months for female mice of all genotypes. Such results are
also supported by other studies (Nelson et al., 1982; Maﬀucci and
Gore, 2006)
ApoE4 Exacerbates Sex-dependent
Learning and Memory in Female AD Mice
The eﬀect of ApoE4 in exacerbating hippocampus-dependent
cognitive impairment in women has been reported in several
clinical studies (Raber et al., 2000; Fleisher et al., 2005; Lehmann
et al., 2006). Here, we used RAWM and NAD tests to assess the
same ApoE4 eﬀect in transgenic mice with triple FADmutations,
who exhibit both amyloid plaque and neuroﬁbrillary tangles
at older age (Oddo et al., 2003). Our ﬁndings, detailed below,
support that female mice are more vulnerable to learning and
memory impairment within the FAD genetic environment, and
that ApoE4 further exacerbates this vulnerability.
We studied hippocampus-dependent learning and memory in
10-month-old male and female nonTg, 3xTg and ApoE4/3xTg
mice using RAWM and NAD tests (Figure 2). Two-day RAWM
training yielded signiﬁcant eﬀects on latency (F7,231 = 40.35,
p < 0.0001 for male; F7,203 = 12.9, p < 0.0001 for female)
and error (F7,231 = 14.2, p < 0.0001 for male; F7,203 = 5.311,
p < 0.0001 for female), with signiﬁcant genotype eﬀect on
latency observed only for female mice (F2,29 = 3.91, p < 0.05)
(Figures 2A–D). Figures 2A,B show signiﬁcantly decreased
latency and error over eight training blocks for male nonTg
(p < 0.05 in block2–block8 vs. block1 for latency; p < 0.05
in block4–block8 vs. block1 for error), 3xTg (p < 0.05 in
block4–block8 vs. block1 for latency; p < 0.05 in block4,
block6–block8 vs. block1 for error) and ApoE4/3xTg mice
(p < 0.05 in block3–block8 vs. block1 for latency; p < 0.05 in
block6–block8 vs. block1 for error), all of which exhibit similar
improvements in performance. However, this comparison in
females showed improved learning only in nonTg (p < 0.05
in block2, block4–block8 vs. block1 for latency; p < 0.05 in
block4, block6–block8 vs. block1 for error) and 3xTg mice
(p < 0.05 in block5–block8 vs. block1 for latency; p < 0.05 in
block7–block8 vs. block1 for error); female ApoE4/3xTg mice
did not improve during the training sessions (Figures 2C,D).
A comparison of each block across all the genotypes studied
revealed a signiﬁcantly longer latency (p < 0.05 in block4 and
block8) and greater error (p < 0.05 in block4) for female
ApoE4/3xTg mice as compared to nonTg mice (Figures 2C,D).
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FIGURE 1 | The spatial memory impairment occurs earlier in female mice carrying ApoE4. Mice were trained in the RAWM for two consecutive days to
learn the location of the target. One hour after the last training, the spatial memory of 10 or 20 months-old nonTg, 3xTg, and ApoE4/3xTg mice was assessed by a
60 s probe trial in RAWM. (A) The age-dependent differences in percentage of time spent in the target arm between young (10 month-old) and old (20 month-old)
nonTg, 3xTg and ApoE4/3xTg mice. Both 10 and 20 month nonTg mice showed a significant longer time spent in the target arm (∗p < 0.001) versus 20% chance.
In Tg mice, only young 3xTg mice showed a significant difference (∗p < 0.001) versus 20% chance and a significant difference (#p < 0.05) versus old; while young
ApoE4/3xTg mice showed a large variation, and neither young nor old Apoe4/3xTg mice showed difference with each other or versus 20% chance. (B) The
sex-dependent differences in percentage of time spent in the target arm in ApoE4/3xTg mice. When comparing ApoE4/3xTg mice with different age by sexes, only
10 month-old ApoE4/3xTg males demonstrated significant difference with 20% chance (∗p < 0.001) and with females (#p < 0.01). N = 8–10 per group. Data is
presented as Mean ± SEM. One sample t-test (vs. 20%). Two-way ANOVA for age and genotype or age and sex differences.
FIGURE 2 | ApoE4 contributes to the sex-dependent early deficits of spatial learning and memory in RAWM and NAD. 10 months-old mice were trained
for two days (four blocks per day, two trials in each block) in RAWM. (A,C) Latency and (B,D) errors that mice took to find the target over eight blocks. During the
training, male mice of all genotypes showed a significant learning pattern (†, ‡, § p < 0.05 vs. block1) as indicated by decreased latency (A) and errors (B). While in
females, the learning pattern was only seen in nonTg and 3xTg mice (†, ‡p < 0.05 vs. block1), but not ApoE4/3xTg mice, as indicated by latency (C) and errors (D).
ApoE4/3xTg females also showed a genotype difference (∗p < 0.05 vs. nonTg). One hour after last training, mice were tested in a probe trial. (E) Percentage of time
mice spent in the target arm during RAWM probe trial. All mice but ApoE4/3xTg females showed a significant difference with 20% chance (∗p < 0.01), and
ApoE4/3xTg mice also demonstrated a sex difference (#p < 0.05 vs. female). (F) Percentage of time mice spent in the novel arm during NAD retention trial. NonTg
mice of both sexes, and 3xTg and ApoE4/3xTg males showed a significant difference with 50% chance (∗p < 0.05). N = 10–12 per group. Data presented as
Mean ± SEM. One sample t-test (vs. 20 or 50%). Two-way ANOVA for training, genotype and sex differences.
Of note, no diﬀerence was observed between nonTg and
3xTg female mice, or between male mice across genotype
(Figures 2A–D).
In RAWM probe trials (Figure 2E), a trend of sex-genotype
interaction eﬀect was observed (F2,60 = 2.853, p = 0.0655). All
male nonTg, 3xTg andApoE4/3xTgmice spent signiﬁcantly more
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than 20% of the time (p < 0.01 for all three genotypes) in the
target arm. For females, however, only nonTg and 3xTg mice
remained in the target arm for signiﬁcantly more than 20% of
the time (p < 0.01 and p < 0.001, respectively) (Figure 2E).
Moreover, when comparing ApoE4/3xTg mice by sex, males
lingered for a signiﬁcantly longer time in the target arm (p< 0.05)
than did females (Figure 2E). No such sex-dependent diﬀerence
was observed for nonTg or 3xTg mice. However, for 3xTg mice,
a diﬀerence was noticed when the testing ITI was prolonged to
1.5 h in the Morris Water Maze (Clinton et al., 2007).
We then tested hippocampus-dependent spatial memory
deﬁcits by using the NAD test, a behavior test that poses less stress
than the RAWM (Figure 2F). Our pilot studies showed that a
1 h ITI between the acquisition and retention trials provides the
greatest sensitivity for detecting sex-dependent diﬀerences in AD
mice. In the retention trials that followed initial exposure within
two of the three maze arms, a signiﬁcant sex eﬀect was observed
(F1,52 = 5.714, p< 0.05). All male nonTg, 3xTg and ApoE4/3xTg
mice spent signiﬁcantly more than 50% of their time (p < 0.001,
p< 0.01, and p< 0.05, respectively) in the novel arm. By contrast,
among females, only nonTg mice spent more than 50% of the
time in the novel arm (p < 0.001) (Figure 2F).
ApoE4 is Associated with More
Prominent AD Pathology in the
Hippocampus of Female AD Mice
To assess cerebral deposition of neurotoxic Aβ, an early and
critical feature of AD, we measured Aβ species expressions,
and protein expressions and enzymatic activities of BACE1,
the rate-limiting enzyme for Aβ production. Our ﬁndings with
dot blot, western blot, and β-secretase activity ﬂuorometric
assays, detailed below, suggest a sex-dependent ApoE4 eﬀect
on increasing BACE1 and Aβ protein expressions, as well
as a sex-independent ApoE4 eﬀect on elevating BACE1
enzymatic activities in the hippocampus of female ApoE4/3xTg
mice.
In dot blot, a signiﬁcant genotype eﬀect (F2,18 = 10.68,
p < 0.001) and sex eﬀect (F1,18 = 4.588, p < 0.05) on Aβ
protein expression were observed (Figure 3). Male nonTg, 3xTg
and 4xTg mice have comparable low Aβ protein expression in
the hippocampus. By contrast, female ApoE4/3xTg mice had
signiﬁcantly higher levels of Aβ than both nonTg (p< 0.001) and
3xTg mice (p < 0.01), as well as signiﬁcantly higher levels than
male ApoE4/3xTg mice (p < 0.05).
Using β-secretase activity ﬂuorometric assay and western blot,
we analyzed BACE1 enzymatic activity and protein expression
in mouse hippocampal extracts. In the β-secretase activity
ﬂuorometric assay (Figure 4A), a signiﬁcant genotype eﬀect was
observed on BACE1 enzymatic activity (F2,12 = 11.21, p< 0.001).
BACE1 activity was signiﬁcantly increased in the hippocampi of
both male (p < 0.01) and female (p < 0.05) ApoE4/3xTg mice.
Female 3xTg mice showed a trend of increased BACE1 activity
(p = 0.058). No sex diﬀerences in BACE1 enzymatic activity
were observed for any of the genotypes here studied. Findings
with western blot (Figure 4B) showed signiﬁcantly eﬀects of
sex (F1,30 = 22.67, p < 0.0001) and sex-genotype interaction
(F2,30 = 6.422, p < 0.01) on BACE1 protein expression.
FIGURE 3 | Female ApoE4/3xTg mice showed more prominent AD
pathology in the hippocampus. Representative image of dot plot on Aβ
levels in hippocampus of nonTg, 3xTg and ApoE4/3xTg mice (upper). The
optical density of dot plot was presented in the graph (lower). Female
ApoE4/3xTg mice demonstrated a significant increase of Aβ (∗p < 0.001 vs.
nonTg, #p < 0.01 vs. 3xTg, †p < 0.05 vs. male). N = 4 per group. Data is
presented as Mean ± SEM. Two-way ANOVA for genotype and sex
differences.
Male nonTg, 3xTg and ApoE4/3xTg mice had comparable low
BACE1 protein levels in the hippocampus; however, both female
3xTg (p < 0.05) and ApoE4/3xTg mice (p < 0.001) had
signiﬁcantly higher BACE1 expression as compared to nonTg
female mice. Moreover, for females, ApoE4/3xTg mice had
even higher BACE1 expression than 3xTg mice (p < 0.05).
When comparing sexes, both female 3xTg (p < 0.001) and
ApoE4/3xTg (p < 0.001) mice had signiﬁcantly elevated protein
levels of BACE1 in the hippocampus than did males of the same
genotype.
ApoE4 is Associated with Increased Sp1,
a BACE1 Transcription Factor, in the
Hippocampus of Female AD Mice
The BACE1 gene promoter carries several transcription factor-
binding sites, one of which is Sp1 which plays a signiﬁcant
role in regulating BACE1 and APP gene expression (Lukiw
et al., 1994; Querfurth et al., 1999; Christensen et al., 2004).
This increased gene transcription may increase BACE1 protein
expression. Using western blot to detect Sp1 expression in the
nuclear protein extracts from hippocampus, we found that female
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FIGURE 4 | Female ApoE4/3xTg mice showed elevated BACE1 enzymatic activity and increased BACE1 and Sp1 expression. (A) The BACE1 enzymatic
activity was examined by β-secretase activity fluorometric assay, and was presented as RFU. The BACE1 enzymatic activity was significantly increased in both male
and female ApoE4/3xTg mice (∗p < 0.05 vs. nonTg), while the female 3xTg mice demonstrated a trend of increase (p = 0.058). (B) BACE1 and (C) Sp1 protein
expressions were assessed by western blot and was presented as relative optical density (ROD). BACE1 protein levels were significantly increased in female Tg
mice, with a greater increase in apoE4/3xTg mice (∗p < 0.001 vs. nonTg, #p < 0.05 vs. 3xTg, †p < 0.001 vs. male) (B). The transcription factor Sp1 was highly
increased in female ApoE4/3xTg mice (∗p < 0.001 vs. nonTg, #p < 0.001 vs. 3xTg, †p < 0.05 vs. male) (C,D) The correlation between Sp1 and BACE1 protein
expression was examined, and a significant correlation was observed (R2 = 3937, p < 0.0001) in female apoE/3xTg mice. N = 3 per group for BACE1 activity
assay. N = 6 per group for western blot. Data is presented as Mean ± SEM. Two-way ANOVA for genotype and sex differences.
AD mice express signiﬁcantly higher levels of Sp1 protein, with
ApoE4 further increasing this elevation in female ApoE4/3xTg
mice. The Sp1 expression was also correlated with the BACE1
expression (Figures 4C,D).
The western blot result from Sp1 expression shows signiﬁcant
eﬀects of sex (F1,30 = 42.09, p < 0.001), genotype (F2,30 = 96.86,
p < 0.0001) and sex-genotype interaction (F2,30 = 50.96,
p< 0.0001). Male nonTg, 3xTg and ApoE4/3xTg mice showed no
diﬀerence in Sp1 expression. However, for females, a higher level
of Sp1 was observed for 3xTg mice (p < 0.05) than for nonTg
mice. Apoe4/3xTg females exhibited a further dramatic elevation
of Sp1 expression as compared to female nonTg (p < 0.001)
and 3xTg (p < 0.001) mice as well as to male ApoE4/3xTg
mice (p < 0.001) (Figure 4C). Moreover, we also observed a
signiﬁcant correlation between hippocampal Sp1 and BACE1
protein expressions (R2 = 0.3937, p < 0.0001), suggesting that,
as a transcription factor of BACE1, the elevated Sp1 expression
may be a molecular mechanism for the increased BACE1 level in
female mice in the current study (Figure 4D).
DISCUSSION
To our knowledge, this study is the ﬁrst to assess age- and
sex-dependent ApoE4 eﬀects on learning and memory and
AD pathology in FAD mutation background (ApoE4/3xTg
mice). Our ﬁndings indicate that a sex-linked interaction with
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ApoE4 may occur across the progression of AD, and that
ApoE4 confers greater AD vulnerability in females than in
males. The exacerbating role of this allele in females was
cumulatively demonstrated in our studies by the earlier and
greater degree of spatial learning and memory impairment
observed in ApoE4/3xTg female mice, as well as by the increased
Aβ deposition, BACE1 and Sp1 protein expression and the
increased BACE1 enzymatic activity in the hippocampus of these
female mice. Our data suggest that the sex-dependent ApoE4
eﬀects on BACE1 expression and activity may contribute to the
Aβ production and be mediated by Sp1 regulation.
Given the baseline concordance of open ﬁeld and rotarod
tests among genotypes and sexes (data not shown), our most
striking behavioral ﬁnding was observed in female ApoE4/3xTg
mice versus that of 3xTgAD and nonTg females. Across the two-
day training, the learning behaviors of female ApoE4/3xTg mice
yielded ﬂat curves both for latency and for errors in ﬁnding the
target. In the RAWM probe trials and the NAD retention trials,
these females also failed to locate the target arm or the novel
arm. These ﬁndings suggest a diminished learning and memory
function in the context of sex-dependent ApoE4 interactions
(Figure 2). During the training trials, female mice in general tend
to have a shorter latency, especially for the ﬁrst two blocks, than
males (Figures 2A,C); given their motor performance, this likely
reﬂected the faster swimming speed measured for these females
(data not shown), possibly due to the lower body mass-related
higher swimming endurance in females (Dohm et al., 1996).
Parallel to our behavioral ﬁndings, we observed a signiﬁcant
increase in the hippocampal Aβ deposition in 10 month-
old female ApoE4/3xTg mice, as compared to age- and sex-
matched nonTg and 3xTg mice (Figure 3). As the critical
enzyme for Aβ production, two aspects of BACE1 that tightly
associated with its function were examined in our study – protein
expression and enzymatic activity (Figures 4A,B). Elevated
BACE1 protein expressions were found in both female 3xTg
and ApoE4/3xTg mice; moreover, a greater increase was seen
in female ApoE4/3xTg versus 3xTg mice. This ﬁnding raises
the possibility that female sex is a major contributor to the
upregulated BACE1 expression in 10 month-old AD mice, and
the sex-dependent ApoE4 eﬀect yields a further increase of
BACE1 expression in females. Moreover, as compared to 3xTg
and nonTgmice, both male and female ApoE4/3xTgmice showed
a signiﬁcant increase in BACE1 enzymatic activities, suggesting a
sex-independent ApoE4 eﬀect in AD mice. The elevated BACE1
protein expression and enzymatic activity in female ApoE4/3xTg
mice may lead to the increased Aβ species and learning and
memory impairments observed in this study.
The abnormal regulation of gene transcription implicated in
AD pathogenesis (Beyreuther et al., 1992) has been associated
with abnormal APP processing, leading to the Aβ increases
seen in AD. The increased BACE1 expression we observed may
also result from the abnormal gene transcription in AD, with
females with ApoE4 gene particularly vulnerable. In our study,
sex-dependent diﬀerences in transgenic mice were seen at age of
10 months, when irregular cycles begin in female mice (Brinton,
2012), possibly leading to the diminished estrogen signaling
and contributing to increased BACE1 protein expression seen
in females of both the 3xTg and ApoE4/3xTg strains. Previous
studies have shown that ovarian hormones, such as estradiol
(E2), can regulate transcription of BACE1 and other secretase
enzymes involved in APP processing (Nord et al., 2010). In
several transgenic mouse models, E2 has been shown to actively
inhibit the BACE1-dependent amyloidogenic pathway (Amtul
et al., 2010; Nord et al., 2010; Bernstein et al., 2011), with
E2 deﬁciency resulting in increased BACE1 levels (Yue et al.,
2005). A recent study suggests that this E2 action may be
regulated through ERs, as ERs mediate luteolin inhibitory eﬀect
on BACE1 transcription (Zheng et al., 2015). A further increased
BACE1 protein expression in ApoE4/3xTg femalesmay be related
to ApoE4 domain interaction induced-endoplasmic reticulum
stress (Zhong et al., 2009). The endoplasmic reticulum stress is
known to activate the PERK-dependent elF2α phosphorylation,
which promotes BACE1 synthesis (Rozpedek et al., 2015).
Transcription factor Sp1 has been demonstrated in vitro and
in vivo to closely regulate BACE1 at the transcription level and
to aﬀect APP processing for the generation of Aβ through the
regulation of BACE1 protein production (Christensen et al.,
2004). Not only does Sp1 bind to the promotor region of
target genes, such as BACE1, to activate the gene transcription,
but its function and expression are also regulated by E2 and
ApoE. It has been shown that ERs form complex with Sp1,
and the ER/Sp1 complex regulates target gene transcriptions
(Krishnan et al., 1994; Duan et al., 1998) in an ER subtype-
dependent fashion (Saville et al., 2000; Safe, 2001). Moreover,
ApoE and E2 regulate transcription factor activities associated
with Sp1 expression, such as NF-κB (Perez et al., 1994; Barger
and Harmon, 1997; Deshpande et al., 1997; Ghisletti et al.,
2005) and CREB (Rohlﬀ et al., 1997; Quesada et al., 2002; Choi
et al., 2004; Li et al., 2014; Yong et al., 2014). After examining
Sp1 expression in our animals, we found its results to be
signiﬁcantly correlated with BACE1 expression, with female 3xTg
mice showing a moderately higher Sp1 protein expression and
female ApoE4/3xTg mice a greater increase (Figures 4C,D). This
data further support that sex-dependent ApoE4 eﬀects may arise
through an increase in Sp1-mediated BACE1 protein expression,
leading to increased Aβ levels. However, Sp1, one of the ﬁrst
identiﬁed eukaryotic transcription factors, has been shown to
play an important role in regulating the expression of many
other genes (Dynan and Tjian, 1983a,b). Further studies are
needed to explore the molecular mechanisms underlying this
pathway.
Although we show here an elevated BACE1 enzymatic activity
in female ApoE4/3xTg mice, and similar results have been
reported in clinical studies (Stockley et al., 2006; Ewers et al.,
2008), the pathway by which ApoE4 increases BACE1 activity
has yet to be demonstrated. ApoE4 has been associated with
increased cholesterol levels in both blood (Corder et al., 1993;
Notkola et al., 1998) and CSF, as measured by the metabolite
24S-hydroxycholesterol, in AD patients (Papassotiropoulos et al.,
2002; Leoni et al., 2006). A further association between increased
cholesterol levels and enhanced BACE1 activity has been shown
in in vitro and in vivo studies (Fassbender et al., 2001; Runz et al.,
2002). ApoE4 may thus inﬂuence Aβ production by modulating
cholesterol levels, leading to their increase and hence increases
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in BACE1 activity (Puglielli et al., 2003; Lahiri et al., 2004).
Another possibility is that ApoE4 may increase BACE1 activity
by stimulating APP recycling (Ye et al., 2005) and thus increasing
intracellular contact of BACE1 to APP.
Sex diﬀerences in cognitive deﬁcits and AD pathology during
disease progression have been widely described in both clinical
studies (Jorm and Jolley, 1998; Andersen et al., 1999; Corder et al.,
2004; Barnes et al., 2005; Rosario et al., 2011) and transgenic
mouse models (Wang et al., 2003; Clinton et al., 2007; Carroll
et al., 2010; Dubal et al., 2012), including 3xTg mice used in
current study. Although our RAWM data did not show, 3xTg
mice did exhibit a sex-dependent diﬀerence in our NAD test
and in the probe trial of Morris water maze with 1.5 and 24 h
ITI in another study (Clinton et al., 2007). The same study also
showed no sex diﬀerences in either soluble or insoluble Aβ40 or
Aβ42 levels in whole brain extracts betweenmale and female 3xTg
mice at any age from 2 to 20 months-old, as measured by ELISA
(Clinton et al., 2007). Similar results were also seen in our dot
blot study using hippocampal tissues of 10 month-old 3xTg mice.
However, a sex-diﬀerence of Aβ load in hippocampal CA1 region
appeared in older (12–14 month) 3xTg mice (Carroll et al., 2010).
Similar Aβ levels between nonTg and 3xTg mice and increased
Aβ levels in female ApoE4/3xTg mice from our results seem
to contradict data from others (Oddo et al., 2003, 2009). This
discrepancy may be due to using animals with diverse age range,
various antibody sensitivity and speciﬁcity as well as diﬀerent
experimental methods. ApoE4/3xTg mice used in current study
were generated by replacing the endogenous mouse ApoE gene
with the humanApoE4 allele in the 3xTgmice (Oddo et al., 2009).
By comparing these two mouse strains, we studied the eﬀect of
human ApoE4 in murine system with human FAD mutations on
learning and memory, BACE1 expression and activity. Further
study with 3xTg mice carrying human ApoE2, 3 or 4 allele will
be beneﬁcial to distinguish the roles of diﬀerent ApoE isoforms
in Aβ and tau depositions in AD mice brains.
CONCLUSION
These data suggest that ApoE4 allele is associated with increased
BACE1 enzymatic activity, while female sex plays an important
role in increasing BACE1 expression. The combination of both
provides a molecular basis for high Aβ pathology and the
resultant hippocampus-dependent learning and memory deﬁcits
in female ApoE4 carriers. Future studies with ovarian hormone
manipulation in ApoE4 female mice are now warranted to probe
the mechanisms underlying AD pathology in postmenopausal
female ApoE4 carriers, and to develop potential therapeutic
targets for this population.
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